ClinicalTrials.gov
public full text
Public Domain
Drug Risk Aversion Calculator Use to Facilitate MS Patient Self-efficacy
The investigators seek to determine if the use of a Side Effect Aversion Calculator helps patients with multiple sclerosis (MS) more comfortably and rapidly identify the disease modifying drug (DMD) that is best suited for the patient.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tysabri Observational Program#1075019
- Effects of a Weight Based Training Program on MS Patients#1032774
- Follow-up of Persons With Multiple Sclerosis#1074876
- RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS#877671
- Mechanistic Studies of Teriflunomide in RRMS#894675
Record · ID 900283
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive